| Ausstehende Aktien | 7,190,876 shares |
| Insider-Aktien | 801.656 shares |
| Insider-Besitz | 11,15 % |
| Insider gesamt | 21 |
Insider-Stimmungswert
Der Insider-Stimmungswert ermittelt die Unternehmen, die von Unternehmensinsidern gekauft werden.
Es ist das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Insiderakkumulation identifiziert. Das Scoring-Modell verwendet eine Kombination aus der Nettozahl der Insiderkäufe der letzten 90 Tage, der Gesamtzahl der gekauften Aktien als Prozentsatz des Streubesitzes und der Gesamtzahl der von Insidern gehaltenen Aktien. Die Zahl reicht von 0 bis 100, wobei höhere Zahlen ein höheres Maß an Insiderkäufen anzeigen als bei anderen Unternehmen und 50 den Durchschnitt darstellt.
Aktualisierungshäufigkeit: Täglich
Führungskräfte-Stimmungswert
Der Führungskräfte-Stimmungswert findet Unternehmen, die von Führungskräften des Unternehmens gekauft werden.
Per Definition sind Führungskräfte des Unternehmens Insider, aber im Gegensatz zu anderen Insidern (10%ige Aktionäre und Vorstandsmitglieder) arbeiten Führungskräfte täglich für das Unternehmen und verwenden beim Handel ihr eigenes Geld. (10%ige Aktionäre und Vorstandsmitglieder sind oft Fondsmanager, die das Geld anderer Leute verwalten.) Daher sind Insider-Geschäfte, die von Führungskräften getätigt werden, viel bedeutender und sollten entsprechend behandelt werden.
Wie der Insider-Stimmungswert ist auch der Führungskräfte-Stimmungswert das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Führungskräftekonzentration identifiziert.
Aktualisierungshäufigkeit: Täglich
Wichtige Insider-Kennzahlen
Diese Karte zeigt, wie das Unternehmen bei verschiedenen Insider-Kennzahlen abschneidet. Der Perzentil-Rang zeigt, wie dieses Unternehmen im Vergleich zu anderen Unternehmen auf den US-Märkten abschneidet. Höhere Ränge deuten auf eine bessere Situation hin.
Es ist beispielsweise allgemein anerkannt, dass Insiderkäufe ein positiver Indikator sind, so dass Unternehmen mit mehr Insiderkäufen besser abschneiden würden als Unternehmen mit weniger Insiderkäufen (oder sogar Insiderverkäufen).
Prozent des Streubesitzes von Insidern gekauft (Rang)
7489 out of 10791
Prozent des von Insidern gekauften Streubesitzes ist die Gesamtzahl der von Insidern gekauften Aktien abzüglich der Gesamtzahl der von Insidern in den letzten 90 Tagen verkauften Aktien, geteilt durch den gesamten Streubesitz und multipliziert mit 100.
Diagramm zum Insiderhandel
Motus GI Holdings, Inc. Insider-Trades sind in der folgenden Grafik dargestellt. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Im Allgemeinen ist es für Insider illegal, auf der Grundlage von wesentlichen, nicht-öffentlichen Informationen mit Aktien ihrer Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden.
Kennzahlen zu Insiderlisten und Rentabilität
Diese Tabelle zeigt die Liste der bekannten Insider und wird automatisch aus den bei der SEC eingereichten Unterlagen erstellt. Zusätzlich zu den Namen, dem letzten Titel und der Bezeichnung als Direktor, leitender Angestellter oder 10%-iger Anteilseigner geben wir die zuletzt veröffentlichten Bestände an. Zusätzlich stellen wir, wenn möglich, die historische Handelsperformance für den Insider zur Verfügung. Die historische Handelsperformance ist ein gewichteter Durchschnitt der Performance tatsächlicher offener Kauftransaktionen, die von dem Insider getätigt wurden. Weitere Informationen zur Berechnung dieses Wertes finden Sie in diesem YouTube-Webinar.
See our leaderboard of most profitable insider traders.
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
| Abv, Llc - | 591.481 | 33.799 | |
| Ascent Biomedical Ventures II, L.P. - | 591.481 | 33.799 | |
|
Joseph Edelman
10% Owner -
|
2.660.542 | 152.031 | |
| Larry N Feinberg - | 0 | 0 | |
| David P Hochman Director - [D] | 291.669 | 16.667 | |
| Jacobs Gary E. Director - [D] | 771.289 | 44.074 | |
| Shervin J Korangy Director - [D] | 190.189 | 10.868 |
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
| Moran Timothy P. Chief Executive Officer, Director - [D] [O] | 657.701 | 37.583 | |
| Samuel R Md Nussbaum Director - [D] | 97.689 | 5.582 | |
| Sonja Nelson Director - [D] | 100.709 | 5.755 | |
|
Oracle Partners Lp
10% Owner -
|
0 | 0 | |
|
Orchestra BioMed Holdings, Inc.
10% Owner -
|
804.096 | 53.606 | |
|
Orchestra BioMed, Inc.
10% Owner -
|
4.000.000 | 228.571 | |
|
Orchestra MOTUS Co-Investment Partners, LLC
10% Owner -
|
2.189.860 | 125.135 |
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
| Orchestra Medical Ventures II GP, LLC - | 0 | 0 | |
|
Perceptive Advisors Llc
10% Owner -
|
2.660.542 | 152.031 | |
|
Perceptive Life Sciences Master Fund Ltd
10% Owner -
|
2.660.542 | 152.031 | |
| Mark Pomeranz President and COO, Director - [D] [O] | 259.857 | 14.849 | |
| Gary J Pruden Director - [D] | 263.116 | 15.035 | |
| Darren Sherman Director - [D] | 194.602 | 11.120 | |
| Andrew Lawrence Taylor Chief Financial Officer - [O] | 230.682 | 13.182 |
Report errors via our new Insider Auditing Tool
Erfolgsbilanz der Insiderkäufe - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in MOTS / Motus GI Holdings, Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Erfolgsbilanz von Insiderverkäufen - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in MOTS / Motus GI Holdings, Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Transaktionshistorie
Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen. Transaktionen, die im Rahmen eines automatischen Handelsplans 10b5-1 gemeldet werden, sind in der Spalte 10b-5 mit einem X gekennzeichnet.
| Datei Datum |
Handel Datum |
Form | Insider | Ticker | Wertpapier-Titel | Code | Direkt | Ausführung Preis |
Einheit Preis |
Eimheiten Verändert |
Wert Geändert (1K) |
Verbleibende Optionen |
Verbleibende Aktien |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-22 | 3 | Orchestra BioMed Holdings, Inc. | MOTS | Common Stock | D | 804.096 | ||||||||
| 2022-02-11 | 2022-02-10 | 4 | Nelson Sonja | MOTS | Stock Option (right to buy) | D | 0,46 | 50.000 | 50.000 | |||||
| 2022-02-11 | 2022-02-10 | 4 | Moran Timothy P. | MOTS | Stock Option (right to buy) | D | 0,46 | 175.000 | 175.000 | |||||
| 2022-02-11 | 2022-02-10 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 175.000 | 657.701 | ||||||
| 2022-02-11 | 2022-02-10 | 4 | Taylor Andrew Lawrence | MOTS | Stock Option (right to buy) | D | 0,46 | 95.000 | 95.000 | |||||
| 2022-02-11 | 2022-02-10 | 4 | Taylor Andrew Lawrence | MOTS | Common Stock, par value $0.0001 per share | D | 95.000 | 230.682 | ||||||
| 2022-02-11 | 2022-02-10 | 4 | Pomeranz Mark | MOTS | Stock Option (right to buy) | D | 0,46 | 95.000 | 95.000 | |||||
| 2022-02-11 | 2022-02-10 | 4 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 95.000 | 259.857 | ||||||
| 2022-02-11 | 2022-02-10 | 4 | Hochman David P | MOTS | Stock Option (right to buy) | D | 0,46 | 50.000 | 50.000 | |||||
| 2022-02-11 | 2022-02-10 | 4 | Korangy Shervin J | MOTS | Stock Option (right to buy) | D | 0,46 | 50.000 | 50.000 | |||||
| 2022-02-11 | 2022-02-10 | 4 | Sherman Darren | MOTS | Stock Option (right to buy) | D | 0,46 | 50.000 | 50.000 | |||||
| 2022-02-11 | 2022-02-10 | 4 | Pruden Gary J | MOTS | Stock Option (right to buy) | D | 0,46 | 50.000 | 50.000 | |||||
| 2022-01-07 | 2022-01-05 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 90.521 | 194.602 | ||||||
| 2022-01-07 | 2022-01-05 | 4 | Nelson Sonja | MOTS | Common Stock, par value $0.0001 per share | D | 82.500 | 100.709 | ||||||
| 2022-01-07 | 2022-01-05 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 127.083 | 291.669 | ||||||
| 2022-01-07 | 2022-01-05 | 4 | Korangy Shervin J | MOTS | Common Stock, par value $0.0001 per share | D | 82.500 | 190.189 | ||||||
| 2022-01-07 | 2022-01-05 | 4 | Pruden Gary J | MOTS | Common Stock, par value $0.0001 per share | D | 106.563 | 263.116 | ||||||
| 2021-11-22 | 2021-11-19 | 4 | Taylor Andrew Lawrence | MOTS | Common Stock, par value $0.0001 per share | D | 0,5106 | 2.000 | 1 | 135.682 | ||||
| 2021-11-22 | 2021-11-19 | 4 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 0,5108 | 4.000 | 2 | 164.857 | ||||
| 2021-11-22 | 2021-11-19 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 0,5214 | 10.000 | 5 | 482.701 | ||||
| 2021-06-23 | 2021-06-22 | 4 | Nelson Sonja | MOTS | Stock Option (right to buy) | D | 1,04 | 50.000 | 50.000 | |||||
| 2021-06-23 | 2021-06-22 | 4 | Nelson Sonja | MOTS | Common Stock, par value $0.0001 per share | D | 18.209 | 18.209 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Moran Timothy P. | MOTS | Stock Option (right to buy) | D | 1,78 | 141.000 | 141.000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 141.000 | 472.701 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Sherman Darren | MOTS | Stock Option (right to buy) | D | 1,78 | 30.000 | 30.000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 22.191 | 104.081 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 30.000 | 81.890 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Pruden Gary J | MOTS | Stock Option (right to buy) | D | 1,78 | 30.000 | 30.000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Pruden Gary J | MOTS | Common Stock, par value $0.0001 per share | D | 26.124 | 156.553 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Pruden Gary J | MOTS | Common Stock, par value $0.0001 per share | D | 30.000 | 130.429 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | NUSSBAUM SAMUEL R MD | MOTS | Stock Option (right to buy) | D | 1,78 | 30.000 | 30.000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | NUSSBAUM SAMUEL R MD | MOTS | Common Stock, par value $0.0001 per share | D | 20.225 | 97.689 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | NUSSBAUM SAMUEL R MD | MOTS | Common Stock, par value $0.0001 per share | D | 30.000 | 77.464 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Taylor Andrew Lawrence | MOTS | Stock Option (right to buy) | D | 1,78 | 60.000 | 60.000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Taylor Andrew Lawrence | MOTS | Common Stock, par value $0.0001 per share | D | 60.000 | 133.682 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Korangy Shervin J | MOTS | Stock Option (right to buy) | D | 1,78 | 30.000 | 30.000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Korangy Shervin J | MOTS | Common Stock, par value $0.0001 per share | D | 20.225 | 107.689 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Korangy Shervin J | MOTS | Common Stock, par value $0.0001 per share | D | 30.000 | 87.464 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Hochman David P | MOTS | Stock Option (right to buy) | D | 1,78 | 40.000 | 40.000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 32.472 | 164.586 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 40.000 | 132.114 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Pomeranz Mark | MOTS | Stock Option (right to buy) | D | 1,78 | 65.000 | 65.000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 65.000 | 160.857 | ||||||
| 2021-02-05 | 2021-01-26 | 4 | FEINBERG LARRY N | MOTS | Common Stock | I | 1,9000 | -30.000 | -57 | 0 | ||||
| 2021-02-05 | 2021-01-26 | 4 | FEINBERG LARRY N | MOTS | Common Stock | I | 1,9034 | -29.115 | -55 | 105.885 | ||||
| 2021-01-22 | 2021-01-22 | 4 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 1,4800 | -550.000 | -814 | 2.660.542 | ||||
| 2021-01-22 | 2021-01-21 | 4 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 1,6800 | -674.352 | -1.133 | 3.210.542 | ||||
| 2021-01-22 | 2021-01-20 | 4 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 1,8000 | -325.648 | -586 | 3.884.894 | ||||
| 2021-01-14 | 2021-01-12 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 9.144 | 51.890 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Pruden Gary J | MOTS | Common Stock, par value $0.0001 per share | D | 10.764 | 100.429 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | NUSSBAUM SAMUEL R MD | MOTS | Common Stock, par value $0.0001 per share | D | 8.334 | 47.464 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Korangy Shervin J | MOTS | Common Stock, par value $0.0001 per share | D | 8.334 | 57.464 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 15.741 | 92.114 | ||||||
| 2020-12-18 | 2020-12-17 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 0,9700 | 3.000 | 3 | 42.746 | ||||
| 2020-12-10 | 2020-12-09 | 4 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 1,0800 | 1.000 | 1 | 95.857 | ||||
| 2020-12-10 | 2020-12-09 | 4 | Taylor Andrew Lawrence | MOTS | Common Stock, par value $0.0001 per share | D | 1,0800 | 1.000 | 1 | 73.682 | ||||
| 2020-12-07 | 2020-12-04 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 0,9930 | 5.000 | 5 | 76.373 | ||||
| 2020-12-07 | 2020-12-04 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 0,9644 | 10.000 | 10 | 331.701 | ||||
| 2020-11-13 | 2020-11-11 | 4 | Pomeranz Mark | MOTS | Stock Option (right to buy) | D | 0,74 | 75.000 | 75.000 | |||||
| 2020-11-13 | 2020-11-11 | 4 | Moran Timothy P. | MOTS | Stock Option (right to buy) | D | 0,74 | 190.000 | 190.000 | |||||
| 2020-11-13 | 2020-11-11 | 4 | Taylor Andrew Lawrence | MOTS | Stock Option (right to buy) | D | 0,74 | 85.000 | 85.000 | |||||
| 2020-10-13 | 2020-10-12 | 4 | Korangy Shervin J | MOTS | Common Stock, par value $0.0001 per share | D | 9.430 | 49.130 | ||||||
| 2020-10-13 | 2020-10-12 | 4 | NUSSBAUM SAMUEL R MD | MOTS | Common Stock, par value $0.0001 per share | D | 9.430 | 39.130 | ||||||
| 2020-10-13 | 2020-10-12 | 4 | Pruden Gary J | MOTS | Common Stock, par value $0.0001 per share | D | 11.132 | 89.665 | ||||||
| 2020-10-13 | 2020-10-12 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 10.346 | 39.746 | ||||||
| 2020-10-13 | 2020-10-12 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 18.466 | 71.373 | ||||||
| 2020-07-13 | 2020-07-10 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 14.600 | 52.907 | ||||||
| 2020-07-13 | 2020-07-10 | 4 | Korangy Shervin J | MOTS | Common Stock, par value $0.0001 per share | D | 7.200 | 39.700 | ||||||
| 2020-07-13 | 2020-07-10 | 4 | Pruden Gary J | MOTS | Common Stock, par value $0.0001 per share | D | 7.700 | 78.533 | ||||||
| 2020-07-13 | 2020-07-10 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 7.900 | 29.400 | ||||||
| 2020-07-13 | 2020-07-10 | 4 | NUSSBAUM SAMUEL R MD | MOTS | Common Stock, par value $0.0001 per share | D | 7.200 | 29.700 | ||||||
| 2020-06-12 | 2020-06-11 | 4 | Moran Timothy P. | MOTS | Stock Option (right to buy) | D | 1,17 | 200.000 | 200.000 | |||||
| 2020-06-12 | 2020-06-11 | 4 | Pomeranz Mark | MOTS | Stock Option (right to buy) | D | 1,17 | 80.000 | 80.000 | |||||
| 2020-06-12 | 2020-06-11 | 4 | Taylor Andrew Lawrence | MOTS | Stock Option (right to buy) | D | 1,17 | 90.000 | 90.000 | |||||
| 2020-02-07 | 2020-02-06 | 4 | Hochman David P | MOTS | Stock Option (right to buy) | D | 2,16 | 20.000 | 20.000 | |||||
| 2020-02-07 | 2020-02-06 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 20.000 | 38.307 | ||||||
| 2020-02-07 | 2019-12-31 | 4 | Hochman David P By NSH 2008 Family Trust | MOTS | Warrants (right to buy) | I | 5,00 | 2.019 | 2.019 | |||||
| 2020-02-07 | 2019-12-31 | 4 | Hochman David P By NSH 2008 Family Trust | MOTS | Warrants (right to buy) | I | 5,00 | 1.766 | 1.766 | |||||
| 2020-02-07 | 2019-12-31 | 4 | Hochman David P | MOTS | Warrants (right to buy) | D | 5,00 | 299 | 599 | |||||
| 2020-02-07 | 2019-12-31 | 4 | Hochman David P | MOTS | Warrants (right to buy) | D | 5,00 | 305 | 305 | |||||
| 2020-02-07 | 2020-02-06 | 4 | NUSSBAUM SAMUEL R MD | MOTS | Stock Option (right to buy) | D | 2,16 | 12.500 | 12.500 | |||||
| 2020-02-07 | 2020-02-06 | 4 | NUSSBAUM SAMUEL R MD | MOTS | Common Stock, par value $0.0001 per share | D | 12.500 | 22.500 | ||||||
| 2020-02-07 | 2020-02-06 | 4 | Pruden Gary J | MOTS | Stock Option (right to buy) | D | 2,16 | 12.500 | 12.500 | |||||
| 2020-02-07 | 2020-02-06 | 4 | Pruden Gary J | MOTS | Common Stock, par value $0.0001 per share | D | 12.500 | 70.833 | ||||||
| 2020-02-07 | 2020-02-06 | 4 | Korangy Shervin J | MOTS | Stock Option (right to buy) | D | 2,16 | 12.500 | 12.500 | |||||
| 2020-02-07 | 2020-02-06 | 4 | Korangy Shervin J | MOTS | Common Stock, par value $0.0001 per share | D | 12.500 | 32.500 | ||||||
| 2020-02-07 | 2020-02-06 | 4 | Sherman Darren | MOTS | Stock Option (right to buy) | D | 2,16 | 12.500 | 12.500 | |||||
| 2020-02-07 | 2020-02-06 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 12.500 | 21.500 | ||||||
| 2020-02-07 | 2020-02-06 | 4 | Pomeranz Mark | MOTS | Stock Option (right to buy) | D | 2,16 | 40.336 | 40.336 | |||||
| 2020-02-07 | 2020-02-06 | 4 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 40.336 | 94.857 | ||||||
| 2020-02-07 | 2020-02-06 | 4 | Taylor Andrew Lawrence | MOTS | Stock Option (right to buy) | D | 2,16 | 46.098 | 46.098 | |||||
| 2020-02-07 | 2020-02-06 | 4 | Taylor Andrew Lawrence | MOTS | Common Stock, par value $0.0001 per share | D | 46.098 | 72.682 | ||||||
| 2020-02-07 | 2020-02-06 | 4 | Moran Timothy P. | MOTS | Stock Option (right to buy) | D | 2,16 | 103.720 | 103.720 | |||||
| 2020-02-07 | 2020-02-06 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 103.720 | 321.701 | ||||||
| 2019-11-20 | 2019-11-20 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 1,5400 | 10.000 | 15 | 217.981 | ||||
| 2019-11-19 | 2019-11-18 | 4 | Jacobs Gary E. By Jacobs Investment Company | MOTS | Common Stock, par value $0.0001 per share | I | 1,5400 | 17.000 | 26 | 771.289 | ||||
| 2019-07-01 | 2019-06-27 | 4 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 3,0000 | 1.000.000 | 3.000 | 4.210.542 | ||||
| 2019-07-01 | 2019-07-01 | 4 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock | I | 2,9896 | 5.000 | 15 | 30.000 | ||||
| 2019-07-01 | 2019-07-01 | 4 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock | I | 3,0158 | 35.000 | 106 | 135.000 | ||||
| 2019-07-01 | 2019-06-27 | 4 | FEINBERG LARRY N | MOTS | Common Stock | I | 3,0000 | 25.000 | 75 | 25.000 | ||||
| 2019-07-01 | 2019-06-27 | 4 | FEINBERG LARRY N | MOTS | Common Stock | I | 3,0000 | 100.000 | 300 | 100.000 | ||||
| 2019-07-01 | 2019-06-27 | 4 | FEINBERG LARRY N | MOTS | Common Stock | I | 3,0000 | 138.698 | 416 | 550.698 | ||||
| 2019-07-01 | 2019-06-27 | 4 | FEINBERG LARRY N | MOTS | Common Stock | I | 3,0000 | 93.566 | 281 | 379.566 | ||||
| 2019-07-01 | 2019-06-27 | 4 | FEINBERG LARRY N | MOTS | Common Stock, par value $0.0001 per share ("Common Stock") | I | 3,0000 | 634.402 | 1.903 | 2.711.402 | ||||
| 2019-07-01 | 2019-07-01 | 4 | Pruden Gary J | MOTS | Common Stock, par value $0.0001 per share | D | 3,0000 | 8.333 | 25 | 58.333 | ||||
| 2019-07-01 | 2019-07-01 | 4 | Hochman David P By DPH 2008 Trust | MOTS | Common Stock, par value $0.0001 per share | I | 3,0000 | 10.000 | 30 | 110.000 | ||||
| 2019-07-01 | 2019-07-01 | 4 | Jacobs Gary E. By Jacobs Investment Company LLC | MOTS | Common Stock, par value $0.0001 per share | I | 3,0000 | 8.333 | 25 | 754.289 | ||||
| 2019-07-01 | 2019-07-01 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 3,0000 | 3.333 | 10 | 207.981 | ||||
| 2019-07-01 | 2019-07-01 | 4 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 3,0000 | 1.000 | 3 | 54.521 | ||||
| 2019-05-24 | 2019-05-22 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 3,3800 | 5.000 | 17 | 204.648 | ||||
| 2019-02-15 | 2019-02-13 | 4 | Sherman Darren | MOTS | Stock Option (right to buy) | D | 4,30 | 25.000 | 25.000 | |||||
| 2019-02-15 | 2019-02-13 | 4 | Hochman David P | MOTS | Stock Option (right to buy) | D | 4,30 | 40.000 | 40.000 | |||||
| 2019-02-15 | 2019-02-13 | 4 | Pruden Gary J | MOTS | Stock Option (right to buy) | D | 4,30 | 25.000 | 25.000 | |||||
| 2019-02-15 | 2019-02-13 | 4 | Korangy Shervin J | MOTS | Stock Option (right to buy) | D | 4,30 | 25.000 | 25.000 | |||||
| 2019-02-15 | 2019-02-13 | 4 | NUSSBAUM SAMUEL R MD | MOTS | Stock Option (right to buy) | D | 4,30 | 25.000 | 25.000 | |||||
| 2019-02-15 | 2019-02-13 | 4 | Jacobs Gary E. | MOTS | Stock Option (right to buy) | D | 4,30 | 25.000 | 25.000 | |||||
| 2019-02-15 | 2019-02-13 | 4 | Pomeranz Mark | MOTS | Stock Option (right to buy) | D | 4,30 | 128.641 | 128.641 | |||||
| 2019-02-15 | 2019-02-13 | 4 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 42.880 | 53.521 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Taylor Andrew Lawrence | MOTS | Stock Option (right to buy) | D | 4,30 | 70.753 | 70.753 | |||||
| 2019-02-15 | 2019-02-13 | 4 | Taylor Andrew Lawrence | MOTS | Common Stock, par value $0.0001 per share | D | 23.584 | 26.584 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Moran Timothy P. | MOTS | Stock Option (right to buy) | D | 4,30 | 28.944 | 28.944 | |||||
| 2019-02-15 | 2019-02-13 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 174.648 | 199.648 | ||||||
| 2019-01-17 | 2018-12-24 | 4 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 2,7000 | 400.000 | 1.080 | 3.210.541 | ||||
| 2019-01-17 | 2018-02-14 | 4 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 5,0000 | 10.000 | 50 | 2.810.541 | ||||
| 2018-12-26 | 2018-12-24 | 4 | Taylor Andrew Lawrence | MOTS | Common Stock, par value $0.0001 per share | D | 2,7000 | 1.000 | 3 | 3.000 | ||||
| 2018-12-26 | 2018-12-24 | 4 | Hochman David P By DPH 2008 Trust | MOTS | Common Stock, par value $0.0001 per share | I | 2,7000 | 20.000 | 54 | 100.000 | ||||
| 2018-12-26 | 2018-12-24 | 4 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 2,7000 | 2.500 | 7 | 10.641 | ||||
| 2018-12-26 | 2018-12-24 | 4 | Jacobs Gary E. By Jacobs Investment Company | MOTS | Common Stock, par value $0.0001 per share | I | 2,7000 | 10.000 | 27 | 745.956 | ||||
| 2018-12-26 | 2018-12-24 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 2,7000 | 10.000 | 27 | 25.000 | ||||
| 2018-12-26 | 3 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock, par value $0.0001 per share | I | 3.187.000 | ||||||||
| 2018-12-26 | 3 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock, par value $0.0001 per share | I | 4.852.000 | ||||||||
| 2018-12-26 | 3 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock, par value $0.0001 per share | I | 3.061.000 | ||||||||
| 2018-12-26 | 3 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock, par value $0.0001 per share | I | 3.187.000 | ||||||||
| 2018-12-26 | 3 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock, par value $0.0001 per share | I | 4.852.000 | ||||||||
| 2018-12-26 | 3 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock, par value $0.0001 per share | I | 3.061.000 | ||||||||
| 2018-12-26 | 3 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock, par value $0.0001 per share | I | 3.187.000 | ||||||||
| 2018-12-26 | 3 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock, par value $0.0001 per share | I | 4.852.000 | ||||||||
| 2018-12-26 | 3 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock, par value $0.0001 per share | I | 3.061.000 | ||||||||
| 2018-11-27 | 2018-11-27 | 4 | Jacobs Gary E. By Jacobs Investment Company | MOTS | Common Stock, par value $0.0001 per share | I | 3,4800 | 7.100 | 25 | 735.956 | ||||
| 2018-11-21 | 2018-11-19 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 3,4800 | 15.000 | 52 | 15.000 | ||||
| 2018-11-21 | 2018-11-16 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 3,4900 | 15.000 | 52 | 18.000 | ||||
| 2018-11-09 | 2018-11-08 | 4 | Moran Timothy P. | MOTS | Stock Option (right to buy) | D | 3,78 | 495.000 | 495.000 | |||||
| 2018-06-11 | 3 | Orchestra BioMed, Inc. | MOTS | Common Stock, par value $0.0001 per share | D | 4.000.000 | ||||||||
| 2018-06-11 | 3 | Orchestra BioMed, Inc. | MOTS | Common Stock, par value $0.0001 per share | D | 4.000.000 | ||||||||
| 2018-06-11 | 3 | Orchestra BioMed, Inc. | MOTS | Common Stock, par value $0.0001 per share | D | 4.000.000 | ||||||||
| 2018-06-04 | 2018-05-31 | 4 | Hochman David P By Orchestra BioMed, Inc. | MOTS | Common Stock, par value $0.0001 per share | I | 2.000.000 | 2.000.000 | ||||||
| 2018-06-04 | 2018-05-31 | 4 | Hochman David P By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | -1.000.000 | 109.792 | ||||||
| 2018-06-04 | 2018-05-31 | 4 | Sherman Darren By Orchestra BioMed, Inc. | MOTS | Common Stock, par value $0.0001 per share | I | 2.000.000 | 2.000.000 | ||||||
| 2018-06-04 | 2018-05-31 | 4 | Sherman Darren By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | -1.000.000 | 109.792 | ||||||
| 2018-06-04 | 2018-05-31 | 4 | Ascent Biomedical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | D | -1.000.000 | 591.481 | ||||||
| 2018-06-04 | 2018-05-31 | 4 | ABV, LLC By Ascent Biomedical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | -1.000.000 | 591.481 | ||||||
| 2018-05-21 | 2018-05-18 | 4 | Jacobs Gary E. By Jacobs Investment Company | MOTS | Common Stock, par value $0.0001 per share | I | 5,2400 | 5.000 | 26 | 728.856 | ||||
| 2018-05-21 | 2018-05-17 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 5,5500 | 1.000 | 6 | 9.000 | ||||
| 2018-05-21 | 2018-05-17 | 4 | Hochman David P By DPH 2008 Trust | MOTS | Common Stock, par value $0.0001 per share | I | 5,4900 | 5.000 | 27 | 80.000 | ||||
| 2018-03-28 | 2018-03-27 | 4 | Pruden Gary J | MOTS | Stock Option (right to buy) | D | 4,58 | 50.000 | 50.000 | |||||
| 2018-02-21 | 3/A | Sherman Darren By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 1.094.930 | ||||||||
| 2018-02-21 | 3/A | Hochman David P By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 1.094.930 | ||||||||
| 2018-02-21 | 3/A | Orchestra Medical Ventures II GP, LLC By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 0 | ||||||||
| 2018-02-21 | 2018-02-16 | 4 | PERCEPTIVE ADVISORS LLC | MOTS | Warrant (right to buy) | I | 5,00 | 180.055 | 180.055 | |||||
| 2018-02-21 | 2018-02-16 | 4 | PERCEPTIVE ADVISORS LLC | MOTS | Series A Convertible Preferred Stock | I | -256.386 | 0 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 5,0000 | 1.000.000 | 5.000 | 2.800.541 | ||||
| 2018-02-21 | 2018-02-16 | 4 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 256.386 | 1.800.541 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Warrants (right to buy) | I | 5,00 | 115.997 | 115.997 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P By Orchestra Medical Ventures II, L.P. | MOTS | Warrants (right to buy) | I | 5,00 | 106.980 | 106.980 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P | MOTS | Warrants (right to buy) | D | 5,00 | 300 | 300 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Series A Convertible Preferred Stock | I | 0,00 | -65.038 | 0 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P By Orchestra Medical Ventures II, L.P. | MOTS | Series A Convertible Preferred Stock | I | 0,00 | -99.748 | 0 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P | MOTS | Series A Convertible Preferred Stock | D | 0,00 | -750 | 0 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 65.038 | 1.159.968 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 99.748 | 1.109.792 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 5,0000 | 40.000 | 200 | 1.010.044 | ||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 750 | 78.000 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 5,0000 | 75.000 | 375 | 77.250 | ||||
| 2018-02-21 | 2018-02-16 | 4 | Pruden Gary J | MOTS | Common Stock, par value $0.0001 per share | D | 5,0000 | 50.000 | 250 | 50.000 | ||||
| 2018-02-21 | 2018-02-16 | 4 | Jacobs Gary E. By Jacobs Investment Company LLC | MOTS | Warrant (right to buy) | I | 5,00 | 72.386 | 72.386 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Jacobs Gary E. By Jacobs Investment Company LLC | MOTS | Series A Convertible Preferred Stock | I | 0,00 | -63.289 | 0 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Jacobs Gary E. By Jacobs Investment Company LLC | MOTS | Common Stock, par value $0.0001 per share | I | 63.289 | 723.856 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | Jacobs Gary E. | MOTS | Common Stock, par value $0.0001 per share | D | 5,0000 | 5.000 | 25 | 9.100 | ||||
| 2018-02-21 | 2018-02-16 | 4 | NUSSBAUM SAMUEL R MD | MOTS | Common Stock, par value $0.0001 per share | D | 5,0000 | 10.000 | 50 | 10.000 | ||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Warrants (right to buy) | I | 5,00 | 115.997 | 115.997 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren By Orchestra Medical Ventures II, L.P. | MOTS | Warrants (right to buy) | I | 5,00 | 106.980 | 106.980 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren | MOTS | Warrants (right to buy) | D | 5,00 | 300 | 300 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Series A Convertible Preferred Stock | I | 0,00 | -65.038 | 0 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren By Orchestra Medical Ventures II, L.P. | MOTS | Series A Convertible Preferred Stock | I | 0,00 | -99.748 | 0 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren | MOTS | Series A Convertible Preferred Stock | D | 0,00 | -750 | 0 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 65.038 | 1.159.968 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 99.748 | 1.109.792 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 5,0000 | 40.000 | 200 | 1.010.044 | ||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 750 | 8.000 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 5,0000 | 5.000 | 25 | 7.250 | ||||
| 2018-02-21 | 2018-02-16 | 4 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 5,0000 | 8.000 | 40 | 8.141 | ||||
| 2018-02-21 | 2018-02-16 | 4 | Ascent Biomedical Ventures II, L.P. | MOTS | Warrant (right to buy) | D | 5,00 | 159.149 | 159.149 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Ascent Biomedical Ventures II, L.P. | MOTS | Series A Convertible Preferred Stock | D | 0,00 | -144.352 | 0 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Ascent Biomedical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | D | 144.352 | 1.591.481 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | Taylor Andrew Lawrence | MOTS | Common Stock, par value $0.0001 per share | D | 5,0000 | 2.000 | 10 | 2.000 | ||||
| 2018-02-21 | 2018-02-16 | 4 | Korangy Shervin J | MOTS | Common Stock, par value $0.0001 per share | D | 5,0000 | 20.000 | 100 | 20.000 | ||||
| 2018-02-21 | 2018-02-16 | 4 | ABV, LLC By Ascent Biomedical Ventures Synecor, L.P. | MOTS | Warrant (right to buy) | I | 5,00 | 61.125 | 61.125 | |||||
| 2018-02-21 | 2018-02-16 | 4 | ABV, LLC By Ascent Biomedical Ventures II, L.P. | MOTS | Warrant (right to buy) | I | 5,00 | 159.149 | 159.149 | |||||
| 2018-02-21 | 2018-02-16 | 4 | ABV, LLC By Ascent Biomedical Ventures Synecor, L.P. | MOTS | Series A Convertible Preferred Stock | I | 0,00 | -26.241 | 0 | |||||
| 2018-02-21 | 2018-02-16 | 4 | ABV, LLC By Ascent Biomedical Ventures II, L.P. | MOTS | Series A Convertible Preferred Stock | I | 0,00 | -144.352 | 0 | |||||
| 2018-02-21 | 2018-02-16 | 4 | ABV, LLC By Ascent Biomedical Ventures Synecor, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 26.241 | 611.241 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | ABV, LLC By Ascent Biomedical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 144.352 | 1.591.481 | ||||||
| 2018-02-13 | 3 | Sherman Darren By Accelerated Technologies, Inc. | MOTS | Common Stock, par value $0.0001 per share | I | 2.253.572 | ||||||||
| 2018-02-13 | 3 | Sherman Darren By Orchestra Medical Ventures II Reserve, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 2.285.426 | ||||||||
| 2018-02-13 | 3 | Sherman Darren By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 3.172.118 | ||||||||
| 2018-02-13 | 3 | Sherman Darren By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 3.297.004 | ||||||||
| 2018-02-13 | 3 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 2.204.324 | ||||||||
| 2018-02-13 | 3 | Sherman Darren By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 3.172.118 | ||||||||
| 2018-02-13 | 3 | Sherman Darren By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 3.297.004 | ||||||||
| 2018-02-13 | 3 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 2.204.324 | ||||||||
| 2018-02-13 | 3 | Sherman Darren By Accelerated Technologies, Inc. | MOTS | Common Stock, par value $0.0001 per share | I | 2.253.572 | ||||||||
| 2018-02-13 | 3 | Sherman Darren By Orchestra Medical Ventures II Reserve, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 2.285.426 | ||||||||
| 2018-02-13 | 3 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 282 | ||||||||
| 2018-02-13 | 3 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 282 | ||||||||
| 2018-02-13 | 3 | Ascent Biomedical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | D | 2.894.258 | ||||||||
| 2018-02-13 | 3 | Ascent Biomedical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | D | 2.894.258 | ||||||||
| 2018-02-13 | 3 | Orchestra Medical Ventures II GP, LLC By Orchestra Medical Ventures II Reserve, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 2.231.678 | ||||||||
| 2018-02-13 | 3 | Orchestra Medical Ventures II GP, LLC By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 3.118.370 | ||||||||
| 2018-02-13 | 3 | Orchestra Medical Ventures II GP, LLC By Orchestra Medical Ventures II Reserve, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 2.231.678 | ||||||||
| 2018-02-13 | 3 | Orchestra Medical Ventures II GP, LLC By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 3.243.256 | ||||||||
| 2018-02-13 | 3 | Orchestra Medical Ventures II GP, LLC By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 3.118.370 | ||||||||
| 2018-02-13 | 3 | Orchestra Medical Ventures II GP, LLC By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 3.243.256 | ||||||||
| 2018-02-13 | 3 | Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | D | 2.189.860 | ||||||||
| 2018-02-13 | 3 | Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | D | 2.189.860 | ||||||||
| 2018-02-13 | 3 | Jacobs Gary E. By Jacobs Investment Company LLC | MOTS | Common Stock, par value $0.0001 per share | I | 1.325.234 | ||||||||
| 2018-02-13 | 3 | Jacobs Gary E. | MOTS | Common Stock, par value $0.0001 per share | D | 668.767 | ||||||||
| 2018-02-13 | 3 | Jacobs Gary E. By Jacobs Investment Company LLC | MOTS | Common Stock, par value $0.0001 per share | I | 1.325.234 | ||||||||
| 2018-02-13 | 3 | Jacobs Gary E. | MOTS | Common Stock, par value $0.0001 per share | D | 668.767 | ||||||||
| 2018-02-13 | 3 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 3.088.310 | ||||||||
| 2018-02-13 | 3 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 3.088.310 | ||||||||
| 2018-02-13 | 3 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 3.088.310 | ||||||||
| 2018-02-13 | 3 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 3.088.310 | ||||||||
| 2018-02-13 | 3 | ABV, LLC By Ascent Biomedical Ventures Synecor, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 2.617.129 | ||||||||
| 2018-02-13 | 3 | ABV, LLC By Ascent Biomedical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 3.479.258 | ||||||||
| 2018-02-13 | 3 | ABV, LLC By Ascent Biomedical Ventures Synecor, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 2.617.129 | ||||||||
| 2018-02-13 | 3 | ABV, LLC By Ascent Biomedical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 3.479.258 | ||||||||
| 2018-02-13 | 3 | Hochman David P By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 3.297.004 | ||||||||
| 2018-02-13 | 3 | Hochman David P By Orchestra Medical Ventures II Reserve, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 2.285.426 | ||||||||
| 2018-02-13 | 3 | Hochman David P By Accelerated Technologies, Inc. | MOTS | Common Stock, par value $0.0001 per share | I | 2.253.572 | ||||||||
| 2018-02-13 | 3 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 2.204.324 | ||||||||
| 2018-02-13 | 3 | Hochman David P By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 3.172.118 | ||||||||
| 2018-02-13 | 3 | Hochman David P By Orchestra Medical Ventures II Reserve, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 2.285.426 | ||||||||
| 2018-02-13 | 3 | Hochman David P By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 3.297.004 | ||||||||
| 2018-02-13 | 3 | Hochman David P By Accelerated Technologies, Inc. | MOTS | Common Stock, par value $0.0001 per share | I | 2.253.572 | ||||||||
| 2018-02-13 | 3 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 2.204.324 | ||||||||
| 2018-02-13 | 3 | Hochman David P By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 3.172.118 |
P
Offener Markt oder privater Kauf von nicht-derivativen oder derivativen Wertpapieren
S
Freiverkauf oder privater Verkauf von nicht-derivativen oder derivativen Wertpapieren
A
Gewährung, Vergabe oder sonstiger Erwerb von Wertpapieren des Unternehmens (z. B. eine Option)
C
Umwandlung von Derivaten
D
Verkauf oder Rückübertragung von Wertpapieren an das Unternehmen
F
Zahlung des Ausübungspreises oder der Steuerschuld mit einem Teil der vom Unternehmen erhaltenen Wertpapiere
G
Schenkung von Wertpapieren durch oder an den Insider
K
Aktien-Swaps und ähnliche Absicherungstransaktionen
M
Ausübung oder Umwandlung eines vom Unternehmen erhaltenen derivativen Wertpapiers (z. B. einer Option)
V
Eine freiwillig auf Formular 4 gemeldete Transaktion
J
Sonstige (mit einer Fußnote zur Beschreibung der Transaktion)
